Non-Invasive Prenatal Testing Market Projected to Reach USD 10.54 Billion by 2030

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Non-Invasive Prenatal Testing Market By Method (Ultrasound Detection, Biochemical Screening Tests, Cell-Free DNA In Maternal Plasma Tests And Others), End-User (Diagnostic Laboratories, Hospitals, Research Centres And Clinics.), Application (Trisomy, Microdelection Syndrome And Others)- Trends, Industry Competition Analysis, Revenue And Forecast To 2030."

The global non-invasive prenatal testing market is estimated to reach over USD 10.54 billion by 2031, exhibiting a CAGR of 12.33% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1425

Non-invasive prenatal testing, commonly referred to as non-invasive prenatal screening, is a technique for assessing the likelihood of genetic disorders in a fetus. This method of checking for Down syndrome, Patau syndrome, Edwards syndrome, and Turner syndrome, among others, is risk-free and incredibly effective. Small DNA fragments present in pregnant women's blood by week 10 of pregnancy are often analyzed to do this. The industry for non-invasive prenatal testing is expanding due to the high risk of chromosomal abnormalities and the rising maternal age. The need for non-invasive prenatal testing is growing as pregnancy beyond 35 has a higher chance of genetic disorders. To ensure babies' healthy deliveries, obstetricians advise their patients to undergo non-invasive tests more frequently, which drives the industry's expansion.
Additionally, it is anticipated that rising research efforts to create cutting-edge technologies will fuel market expansion. The cost-effectiveness of non-invasive prenatal testing is growing due to technology improvements, which are anticipated to support market expansion in the upcoming years.